Deposits on the intraluminal surface and bacterial growth in central venous catheters

Journal of Hospital Infection

Volumn 75, Issue 1, 2010, Pages 19-22

  Nishikawa, K ^a   Takasu, A ^a   Morita, K ^a   Tsumori, H ^a   Sakamoto, T ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Bacteria; Central venous catheterisation; Infection; Scanning electron microscopy

Indexed keywords

ACINETOBACTER BAUMANNII; ARTICLE; BACILLUS CEREUS; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM ADHERENCE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BIOFILM; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; CRYSTALLIZATION; ENTEROCOCCUS FAECALIS; INTENSIVE CARE; NONHUMAN; PARENTERAL NUTRITION; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS HAEMOLYTICUS;

BACTERIA; CATHETERIZATION; CATHETERIZATION, CENTRAL VENOUS; CRITICAL ILLNESS; EQUIPMENT AND SUPPLIES; HUMANS; INTENSIVE CARE UNITS; MICROSCOPY, ELECTRON, SCANNING;

EID: 77951296031     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.11.005     Document Type: Article

References (11)

1. Raad I.I., Hanna H., Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007, 7:645-657.
2. Veenstra D.L., Saint S., Saha S., et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. J Am Med Assoc 1999, 281:261-267.
3. Falagas M.E., Fragoulis K., Bliziotis I.A., et al. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2007, 59:359-369.
4. Mikkelsen H., Duck Z., Lilley K.S., et al. Interrelationships between colonies, biofilms, and planktonic cells of Pseudomonas aeruginosa. J Bacteriol 2007, 189:2411-2416.
5. NCCLS Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement M100-S15 2005, Providing NCCLS standards and guidelines, ISO/TC 212 standards, and ISO/TC 76 standard. 25(1), NCCLS, Wayne, PA.
6. Dobbins B.M., Catton J.A., Kite P., et al. Each lumen is a potential source of central venous catheter-related bloodstream infection. Crit Care Med 2003, 31:1688-1690.
7. Randolph A.G., Cook D.J., Gonzales C.A., et al. Benefit of heparin in central venous and pulmonary artery catheters: meta-analysis of randomized controlled trials. Chest 1998, 113:165-171.
8. Pearson M.L. Guideline for prevention of intravascular-device-related infections: Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996, 17:438-473.
9. Brun-Buisson C., Doyon F., Sollet J.P., Cochard J.F., Cohen Y., Nitenberg G. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Med 2004, 30:837-843.
10. Ostendorf T., Meinhold A., Harter C., et al. Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients - a double-blind, randomised, prospective, controlled trial. Support Care Cancer 2005, 13:993-1000.
11. Rupp M.E., Lisco S.J., Lipsett P.A., et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005, 143:570-580.